RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

OT: Galleon and RD

No one regulates press releases, and Galleon likely thought it not helpful to say 'this is the second time--and the people who did it first couldn't raise money either."

Galleon has been around since 2005, hoping to develop s-nitrosylating agents for RD and sleep apnea.

Galleon said this in 2006:

<<Galleon received $500,000 from
BioAdvance in 2005. Galleon is raising
a $5 million Series A round primarily
to support two (2) Phase IIa proof-of-concept
clinical trials scheduled to begin
in 2007.>>

In 2008, they had claimed to have shown 'POC' in trial, but gave no details. Five years later, they have finished a 12 pt trial, and are still hoping to raise money to do an actual Phase II.

NP